Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran)
Open Access
- 1 November 1996
- journal article
- case report
- Published by Oxford University Press (OUP)
- Vol. 72 (853) , 688-689
- https://doi.org/10.1136/pgmj.72.853.688
Abstract
Summary: Ondansetron is a 5-hydroxytryptamine receptor antagonist which is known to be a highly effective anti-emetic drug for chemotherapy-associated nausea and vomiting and for postoperative nausea. We report here a case where ondansetron was used in severe hyperemesis gravidarum to avoid parenteral nutrition. The drug was used intermittently in every trimester with no apparent adverse effects on mother or infant.Keywords
This publication has 6 references indexed in Scilit:
- Ondansetron and hyperemesis gravidarumThe Lancet, 1993
- Ondansetron and hyperemesis gravidarumThe Lancet, 1992
- Ondansetron in the Treatment of Postoperative VomitingAnesthesia & Analgesia, 1992
- Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting.1989
- Pharmacological and anti-emetic properties of ondansetron.1989
- Clinical studies with ondansetron in the control of radiation-induced emesis.1989